Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117
Jeffrey D. Bradley, Kyounghwa Bae, Mary V. Graham, Roger Byhardt, Ramaswamy Govindan, Jack Fowler, James A. Purdy, Jeff M. Michalski, Elizabeth Gore, Hak Choy
Dive into the research topics of 'Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117'. Together they form a unique fingerprint.